InstructorRoyed Training
TypeOnline Course
Price$690 USD / 34500 INR.
Buy NowBook Now
Loading
Loading
free resources at royed training
pharma strategic management course

Introduction

Learning Areas

Features

Eligibility

Certification

Related Courses

About strategic management

pharma strategic management course

This online training provide understanding of pharma strategic business management skills which are commonly applied in the pharma and biotech companies. The course is designed to create the new-edged Strategic Business Manager for pharma and biotech industry. Course focuses on how pharma and biotech strategic business manager works and their key responsibilities and job functions.

Course Code: RYD-005

Key Learning Area for the course

  • Drug Development to Commercialization.
  • Innovation Management in pharmaceutical industry.
  • Pharma Marketing Strategic Planning.
  • Generic Drug Strategic Planning.
  • Managing pharmaceutical SBU (strategic business unit) revenue model.
  • Region specific pharma business strategies.
  • International Marketing strategic planning in pharmaceutical.
  • Deals and deal management in pharmaceutical and bio pharmaceutical industry.
  • Deal valuation tools and techniques.
  • Pharmaceutical Business Audit – Due diligence.
  • Financial Planning and Management for pharma strategic management professionals.
  • Advance soft skill training for pharma strategic management professionals.
  • Understanding on pharma strategic business management principles involved from drug discovery development to commercialization. Therefore fundamental to advance R&D management process training is included.
  • Additionally, the course provide pharma portfolio management skill training.
  • Advance Simulation provide to real life learning experience. Hence it helps to improve the decision making skills of the participants.
  • Biotech, biosimilar products strategic management is also part of the course.
  • Above all, course participants are exposed to Global Pharma Business Case Studies.
  • 24×7 access of the course. Hence you can attend the course at your own preferred date and time.

Minimum qualification Graduation in any discipline.

Certificate will be provided at the end of the successful completion of the course.

Related courses

What is strategic management in pharma and biotech industry?

  • Strategic management is the process of planning, monitoring, analysis and assessment of all what is must for an organization to meet its goals and objectives. Because of this, in all leading pharma and biotech companies, there is a separate division called strategic management cell. They work on planning organization’s strategy.
  • Pharma strategic management professionals involve in changes in organization’s business process. As a result, they bring the success to organization.
  • Today pharma and biotech organization are looking for trained professionals who understand all aspects of strategic planning. However, there is a lack of professionals who understand complex pharma and biotech business environment.

What skill Pharma Strategic Manager should have?

Firstly, Pharma Strategic Manager should be master of the drug discovery, development to commercialization process. They should have excellent and updated regulatory knowledge. Secondly, professionals should have the fundamental understanding on portfolio management process. Thirdly, they should have strategic business skills, acumen and competency. Last but not the least, they should have basic financial management skills. Most importantly, the course covers deal valuation tools and techniques.

To summarize, strategic management professionals should have overall pharma business functional understanding.

Do the course cover both pharmaceutical and biopharmaceutical strategic management?

  • Yes. It’s cover the both pharmaceutical and biopharmaceutical industry.

.

Section 1INTRODUCTION TO PHARMACEUTICAL STRATEGIC MANAGEMENT
Lecture 1Introduction to R&D Process & drug discovery
Lecture 2Investigational New Drug Application
Lecture 3New Drug Application (NDA)
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA)
Lecture 6Review on Drug Discovery and Development
Lecture 7Strategic management – Strategic decision making – business level sub strategies
Lecture 8Expedited Drug Development Program
Lecture 9Practical Training on INDA, NDA, ANDA filing
Lecture 10505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 11Authorized Generics: Key Understanding
Lecture 12Exploratory IND Vs. Traditional IND
Lecture 13Patents Vs. exclusivity
Lecture 14Strategic Learning from New Drug Development
Lecture 15Orphan Drug Designation
Lecture 16Advance Strategic Learning on 505B2 Pathway
Section 2CLINICAL RESEARCH - PHARMA R&D STRATEGIC ORIENTATION
Lecture 17Clinical Trial Terminologies
Lecture 18Clinical Trial Protocol Writing
Lecture 19Ethics in Clinical Research
Lecture 20Informed Consent
Lecture 21Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !
Section 3INTELLECTUAL PROPERTY MANAGEMENT
Lecture 22Patent and Trademark Office - How they work?
Lecture 23 Patent
Lecture 24 Application For Patent
Lecture 25Trademark
Lecture 26 Steps Know How & Key Points - Patent Application
Lecture 27 Fundamental Understanding of Patent, Trademark Licensing and related terminology
Section 4PHARMA MARKETING - BRAND MANAGEMENT
Lecture 28 Introduction to Pharma Marketing
Lecture 29Market Research in Pharma Business
Lecture 30 Consumer buying behavior
Lecture 31Product Life cycle - Basic Understanding
Lecture 32 STP - Strategic Positioning and Brand Differentiation
Lecture 33 Pricing Strategies
Lecture 34Distribution and Logistics
Lecture 35 Pharmaceutical Distribution
Lecture 36Promotion Management Process in a Pharmaceutical Company
Lecture 37 Setting and Quantifying Promotional Objectives
Lecture 38Promotional Budget Setting : Tools and Techniques
Lecture 39Basics of Advertising : Introduction
Lecture 40 Classifications of Advertising
Lecture 41 The Advertising agency
Lecture 42Classification of Doctors
Lecture 43 Moving Annual Total (MAT)
Lecture 44 CAGR
Lecture 45 Brand Potential
Section 5PHARMA BRAND STRATEGY MANAGEMENT
Lecture 46PRATICAL TRAINING SESSION : BRAND NAME, BRAND LOGO, TRADEMARKING
Lecture 47 Purpose of Pharma Brand Logo
Lecture 48Component of brand logo
Lecture 49Brand Name and TM Registration Process
Lecture 50How to design excellent brand logo?
Lecture 51Case study in brand name finalization
Lecture 52Brand Name Simulation
Lecture 53 Traditional Vs. Non-Traditional trademark
Lecture 54 Global Protection of the Pharma Brand
Lecture 55Rebranding in Pharmaceuticals
Lecture 56Brand Logo Development: Real Life Simulation
Lecture 57 Fundamental of Pharma Marketing Plan
Lecture 58Basic Know-How: Marketing Campaign Development
Lecture 59How to prepare a Pharma Brand Plan
Lecture 60 Decide about brand USP -What to promote
Lecture 61 How to prepare promotogram. Download sample Promotogram
Lecture 62Sample Allocation
Lecture 63 Importance of Visual Aid in Pharmaceutical Industry
Lecture 64BUYING SIGNAL
Lecture 65 Indications for Drugs: Approved vs. Non-approved
Lecture 66Case Study : Indication approval to extend the usage of the brands (molecule)
Lecture 67Step By Step Visual Aid Designing
Lecture 68 Guideline of Visual Aid Designin
Lecture 69Practical Sample to understand visual aid contents and effective placement of the texts
Lecture 70 VISUAL AID PRINTING
Lecture 71 Detailing and e-detailing
Lecture 72 Marketing Plan followed by Visual Aid Development
Lecture 73Visual Aid, Literature reference Sample
Lecture 74 Creativity to develop brand essence
Lecture 75 Increase the brand reach with advance segmentation
Lecture 76 Concept of uniform branding for better brand acceptability
Lecture 77Concept of Brand Differentiation
Section 6BIOPHARMACEUTICALS AND BIOSIMILAR DEVELOPMENT PROCESS
Lecture 78Introduction : Biopharmaceuticals
Lecture 79 Classification of Biopharmaceutical
Lecture 80Introduction to Biosimilar
Lecture 81 Chemical Drugs Vs. Biologic Drugs
Lecture 82 Current Trends in Biopharmaceutical Market
Lecture 83Complexity of biopharma supply chain and operations
Lecture 84Biopharma - Market Segmentation
Lecture 85Blockbuster Biologic - Classifications, Indications, Global Sales
Lecture 86Recombinant protein
Lecture 87Monoclonal Antibodies Vs. Polyclonal Antibodies
Lecture 88Monoclonal Antibodies
Lecture 89Synthetic Immunomodulators
Lecture 901Production of Monoclonal Antibodies
Lecture 91Cytokines
Lecture 92Interferon
Lecture 93Erythropoiesis-stimulating agent
Lecture 94Biological Licensing Application (BLA)
Lecture 95Biosimilar Approval process
Lecture 96Difference : Drugs Vs. Biopharmaceutical Approval process
Lecture 97Pricing and cost effectiveness of biosimilars
Lecture 98Exclusivity Protections for Biopharmaceuticals
Lecture 99REMS Strategic Planning
Lecture 100Review : 351(a) vs. 351(k) pathway
Section 7STRETGIC PLANNING IN PHARMACEUTICALS & BIOPHARMACEUTICALS
Lecture 101Strategies in different phases of Clinical Trial
Lecture 102Lifecycle Extension Strategies - Evergreening
Lecture 103Advance Study in Para IV filing
Lecture 104Evergreening - Patent Life Extension Strategies
Lecture 105Pay For Delay Strategy
Lecture 106Compulsory Licensing
Lecture 107Licensing Vs. Outlicensing
Lecture 108LOE Strategies for Innovator Brands with case study
Lecture 109Paediatric Exclusivity and Paediatric Study Plan Development
Lecture 110Drug Repurposing
Section 8ADVANCE PORTFOLIO MANAGEMENT
Lecture 111Advance understanding of the portfolio Management
Lecture 112Co-promotion & Co-marketing strategy
Lecture 113Reverse co-promotion
Lecture 114New Indication Approval Process and Promotion
Lecture 115Publication Management for strategic positioning of the brands
Lecture 116Juxtapid Case Study
Lecture 117OTC Switch
Lecture 118Rx to OTC switch - case study
Section 9STRATEGIC ORIENTATION IN PHARMA AND BIOPHARMA INDUSTRY
Lecture 119Licensing Vs. Outlicensing in Pharma / Biopharma Industry
Lecture 120Licensing - Advance Strategic Learning
Lecture 121Terms / Duration of License
Lecture 122Are improvements licensed
Lecture 123Financial of Licensing Deals
Lecture 124Milestone Payment
Lecture 125How are royalties structured in a licensing deal?
Lecture 126What accounts, inspection and audit provisions are in a license?
Lecture 127How is patenting dealt with in a license?
Lecture 128What warranties are in a license?
Lecture 129What competition law issues are there in licensing?
Lecture 130Co-development and co-marketing agreements in Pharmaceutical Strategic Management
Lecture 131Due Diligence Activities in Pharmaceutical Licensing
Lecture 132Detailed in-depth strategic understanding on Technology Transfer
Lecture 133Overview of contractual agreements in Technology Transfer
Lecture 134Confidentiality agreements
Lecture 135Material Transfer Agreements
Lecture 136Deeds of assignment or assignment deeds
, ,